28/06/2005 - 22:00

Visiomed enters trials

28/06/2005 - 22:00

Bookmark

Save articles for future reference.
Visiomed enters trials
BIOMEDICAL services developer Visiomed Group has announced that its opthalmic imaging system microEYE, developed in conjunction with Alternative Investment Market-listed CustomVis, has begun a clinical evaluation trial. The microEYE is a hand-held camera system capable of imaging different regions of the eye using a single device. The system is designed for use in the diagnosis and monitoring of eye diseases including cataracts, glaucoma, trachoma, macular degeneration and diabetic retinopathy. In addition to the microEYE system, Visiomed manufactures and sells the Funhaler, an asthma drug delivery device designed specifically for children.

STANDING BY BUSINESS. TRUSTED BY BUSINESS.

Subscription Options